Ingersoll Rand (IR)
Makes compressors, pumps, and precision fluid-handling systems for industrial and life-science processes.
Something off on this page? Send us feedback.
Manufactures compressors, vacuum systems, blowers, pumps, and precision fluid- and powder-handling equipment for industrial and life-science customers worldwide. Original-equipment sales seed an installed base that generates recurring parts, consumables, repair, and support revenue.
Designs, manufactures, and services compressors, vacuum pumps, blowers, air-treatment systems, power tools, lifting equipment, and fluid-transfer equipment through Industrial Technologies and Services. Precision and Science Technologies supplies pumps, dosing and dispensing systems, gas-management equipment, powder-handling systems, and life-science tools for customers spanning manufacturing, food and beverage, energy, water, and biopharmaceutical markets worldwide.
Combines application engineering, a broad brand portfolio, and a global manufacturing and service footprint to support process-critical equipment where downtime is costly. Acquisitions regularly extend both segments and adjacent technologies. Revenue comes from original equipment and a sizable recurring stream of replacement parts, consumables, repairs, and support; sales flow through direct teams and independent distributors.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 10, 2026 | Morgan Stanley | Target | Target: $80 | Target: $87 |
| Jul 20, 2026 | Stifel Nicolaus | Target | Target: $90 | Target: $84 |
| Jun 3, 2026 | Morgan Stanley | Reiterate | Rating: —Target: $97 | Target: $80 |
| May 11, 2026 | Evercore ISI | Target | Target: $53 | Target: $84 |
| Apr 30, 2026 | Robert W. Baird | Target | Target: $115 | Target: $103 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $1.17B · Total debt $4.83B · Total assets $18.19B · Shareholders' equity $10.18B
- Revenue
- $2.05B
- Operating income
- $380.3M
- Net income
- $256.8M
HistoryDividendAnnual yield
| Institutions | ≈ 103.17% | 400.32M shares | |
|---|---|---|---|
| 921 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.17% | 649.7K shares | |
| 19 holders · as of Aug 21, 2026 | |||
| Adds to | 103.34% | ||
388.00M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 103.34%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 7.81% | 30.30M | as of Jun 30, 2026 |
Capital World InvestorsInstitution | 7.20% | 27.93M | as of Jun 30, 2026 |
Price T Rowe Associates Inc /MD/Institution | 6.97% | 27.03M | as of Jun 30, 2026 |
Capital Research Global InvestorsInstitution | 6.50% | 25.22M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.31% | 24.48M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 3, 2026 | Aurobind Satpathy | director | +11,538 | $86.68 |
| Apr 13, 2026 | Vicente Reynal | director, officer: See Remarks | −30,492 | $88.00 |
| Mar 2, 2026 | Vicente Reynal | director, officer: See Remarks | −118,044 | $94.11 |
| Feb 20, 2026 | Vikram Kini | officer: Senior Vice President and CFO | −28,367 | $96.50 |
| Feb 19, 2026 | John Humphrey | director | −4,300 | $95.90 |
- Danaher
Dominant in biopharma bioprocessing — Cytiva and Pall directly face ILC Dover.
- IDEX
The only peer named in both IT&S and P&ST sections of IR's 10-K.
- Flowserve
IT&S-named principal competitor — pumps, valves, seals for process industries.
- Dover
P&ST-named — Pumps & Process Solutions spans biopharma and industrial fluids.
- Repligen
Pure-play single-use bioprocess — XCell ATF, TFF filtration, fluid management.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Ingersoll Rand | $73.46 | +1.59% | $28.30B | 29.8 | 19.8 | 3.6 | +8.5% |
| Danaher | $221.25 | +2.51% | $151.67B | 38.3 | 25.0 | 6.0 | +5.5% |
| IDEX | $226.47 | +1.77% | $16.40B | 32.0 | 24.8 | 4.6 | +6.4% |
| Flowserve | $75.31 | +0.86% | $9.57B | 26.2 | 17.3 | 2.1 | −1.6% |
| Dover | $186.35 | +0.14% | $25.06B | 22.5 | 16.6 | 3.0 | +6.9% |
| Repligen | $185.90 | +2.87% | $10.20B | 247.5 | 82.3 | 13.0 | +11.9% |
| Median | 32.0 | 24.8 | 4.6 | +6.4% |